The addition of metformin “was generally well tolerated but did not result in the targeted benefit of a 20% reduction in risk of death in an unselected population,” the researchers wrote.

Mass firings and grant terminations have disrupted research and other operations at the National Cancer Institute.

Olaparib demonstrated activity in a phase 2 trial of patients who had advanced biliary tract cancer with homologous recombination repair (HRR) mutations. Results from this trial were presented at the ...

Cancer Therapy Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

The Trump administration's recent travel and visa restrictions are preventing medical residents from starting their jobs in the US.

Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term adverse effects such as second malignancies and infertility, ...

The NIH is planning to limit how much publishers can charge NIH-supported scientists to make their research findings publicly available.

The denosumab biosimilars Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) are now available in the US.

In June, the US Food and Drug Administration approved 7 drugs to treat a range of cancers.

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

The lawsuit was prompted by steps the HHS has taken to “mislead, confuse, and gradually desensitize the public to anti-vaccine and anti-science rhetoric,” according to the plaintiffs.

This article was originally published on Stateline. The giant tax and spending bill President Donald Trump signed into law over the weekend includes the biggest health care spending cuts in U.S.